##plugins.themes.academic_pro.article.sidebar##

Download
pdf
Statistic
Read Counter : 88 Download : 81

##plugins.themes.academic_pro.article.main##

Abstract

One of the most prevalent chronic, complex neurovascular illnesses, migraine, is primarily defined by recurring bouts of incapacitating headaches with aura appearances in up to one-third of patients. Nearly 15% of people get migraines, making it the third most common sickness in the world. Objective: This paper aims to study hypoperfusion during migraines and its Effect on the Retina

Keywords

RNFL thickness migraine symptoms

##plugins.themes.academic_pro.article.details##

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

How to Cite
Dr. Ahmad Nezar Abdulhamid, Dr. Daniah Radhi Abed, & Dr. Sameer Hameed Hammadi. (2023). Hypoperfusion During Migraine and its Effect on the Retina. Texas Journal of Medical Science, 20, 129–137. https://doi.org/10.62480/tjms.2023.vol20.pp129-137
Crossref
Scopus
Google Scholar
Europe PMC

References

  1. Stovner L.J., Hagen K., Jensen R., Katsarava Z., Lipton R., Scher A., Steiner T., Zwart J.A. The global burden of headache: A documentation of headache prevalence and disability worldwide. Cephalalgia. 2007;27:193–210.
  2. Ferroni P., Barbanti P., Della-Morte D., Palmirotta R., Jirillo E., Guadagni F. Redox mechanisms in migraine: Novel therapeutics and dietary interventions. Antioxid. Redox Signal. 2018;28:1144–1183.
  3. Bulboacă A., Dogaru G., Blidaru M., Bulboaca A.C., Stănescu I. Evaluation of oxidative stress in migraine patients with visual aura—the experience of an Rehabilitation Hospital. Balneo Res. J. 2018;9:303–308.
  4. Martin H., Sanchez del Rio M., de Silanes C.L., Alvarez-Linera J., Hernandez J.A., Pareja J.A. Photoreactivity of the occipital cortex measured by functional magnetic resonance imaging-blood oxygenation level-dependent in migraine patients and healthy volunteers: Pathophysiological implications. Headache. 2011;51:1520–1528.
  5. Denuelle M., Boulloche N., Payoux P., Fabre N., Trotter Y., Geraud G. A PET study of photophobia during spontaneous migraine attacks. Neurology. 2011;76:213–218.
  6. Huang J., Zong X., Wilkins A., Jenkins B., Bozoki A., Cao Y. fMRI evidence that precision ophthalmic tints reduce cortical hyperactivation in migraine. Cephalalgia. 2011;31:925–936.
  7. Borkum J.M. Migraine triggers and oxidative stress: A narrative review and synthesis. Headache. 2016;56:12–35.
  8. Förster A., Wenz H., Kerl H.U., Brockmann M.A., Groden C. Perfusion patterns in migraine with aura. Cephalalgia. 2014;34:870–876.
  9. Ekinci M., Ceylan E., Cağatay H.H., Keleş S., Hüseyinoğlu N., Tanyildiz B., Cakici O., Kartal B. Retinal nerve fiber layer, ganglion cell layer and choroid thinning in migraine with aura. BMC Ophthalmol. 2014;14:75.
  10. Reggio E., Chisari C.G., Ferrigno G., Keleş S., Hüseyinoğlu N., Tanyildiz B., Cakici O., Kartal B. Migraine causes retinal and choroidal structural changes: Evaluation with ocular coherence tomography. J. Neurol. 2017;264:494–502.
  11. Sacco S., Ricci S., Carolei A. Migraine and vascular diseases: A review of the evidence and potential implications for management. Cephalalgia. 2012;32:785–795.
  12. Larrosa-Campo D., Ramón-Carbajo C., Para-Prieto M., Calleja-Puerta S., Cernuda-Morollón E., Pascual J. Migraine as a vascular risk factor. Rev. Neurol. 2012;55:349–358.
  13. Bulboacă A.E., Blidaru M., Dogaru G., Bulboacă A., Stănescu I.C. The effect of nitro-oxidative stress on platelet aggregability in migraine patients in a Rehabilitation Hospital—A pilot study. Balneo Res. J. 2018;9:385–389.
  14. Bulboacă A.E., Bolboacă S.D., Stănescu I.C., Sfrângeu C.A., Porfire A., Tefas L., Bulboacă A.C. The effect of intravenous administration of liposomal curcumin in addition to sumatriptan treatment in an experimental migraine model in rats. Int. J. Nanomed. 2018;13:3093–3103.
  15. Lukacs M., Tajti J., Fulop F., Toldi J., Edvinsson L., Vecsei L. Migraine, neurogenic inflammation, drug development—Pharmacochemical aspects. Curr. Med. Chem. 2017;24:3649–3665.
  16. Yücel M., Kotan D., Gurol Çiftçi G., Çiftçi I.H., Cikriklar H.I. Serum levels of endocan, claudin-5 and cytokines in migraine. Eur. Rev. Med. Pharmacol. Sci. 2016;20:930–936.
  17. Aguggia M., Saracco M.G., Cavallini M., Bussone G., Cortelli P. Sensitization and pain. Neurol. Sci. 2013;34:S37–S40. doi: 10.1007/s10072-013-1382-0.
  18. Friedman D.I. The eye and headache. Continuum. 2015;21:1109–1117.
  19. Russo A., Tessitore A., Tedeschi G. Migraine and trigeminal system-I can feel it is coming. Curr. Pain Headache Rep. 2013;17:367.
  20. Shayestagul N.A., Christensen C.E., Amin F.M., Ashina S., Ashina M. Measurement of blood flow velocity in the middle cerebral artery during spontaneous migraine attacks: A systematic review. Headache. 2017;57:852–861.